NCT07516353
- Conditions
- ALL, AML, Acute Lymphoblastic Leukemia ,Lymphomas, +32 more
- Locations
-
- Dana Farber Cancer Institute Boston, Massachusetts, United States
Clinical trial condition
Acute Lymphoblastic Leukemia ,Lymphomas
Explore clinical trials studying Acute Lymphoblastic Leukemia ,Lymphomas. Study availability and eligibility vary by location and protocol.
1 public trial
0 recruiting studies